
Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies
NETCast
00:00
Hypermutation, Alkylators, and ICI Considerations
Aman Chauhan reviews cases of post-alkylator hypermutation and cautious interest in immunotherapy trials for NECs.
Play episode from 14:33
Transcript


